Trial Details
Not RecruitingBasic Information
| Clinical ID | c2763 |
|---|---|
| Identifier | EUCTR2018-001546-33-GB |
| Trial Title | IBD Biosimilar to Biosimilar Infliximab Switching Study - iBiSS v1.0 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | Inflammatory Bowel Disease in particular Crohn's Disease and Ulcerative Colitis MedDRA version: 20.1_Level: PT_Classification code 10021972_Term: Inflammatory bowel disease_System Organ Class: 10017947 - Gastrointestinal disorders_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: Flixabi Product Name: Flixabi Pharmaceutical Form: Infusion INN or Proposed INN: Infliximab CAS Number: 170277-31-3 Concentration unit: mg milligram(s) Concentration type: equal |
Participant Information
| Sponsor | University Southampton Hospital NHS Foundation Trust |
|---|---|
| City | - |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |